Skip to content

VHCP Management III, LLC

Follow

13F filer, CIK 1738053, New York, NY

VHCP Management III, LLC reported $161,989,000 across 17 holdings for the quarter ended 2019-09-30, in a 13F-HR filed 2019-11-13. Its ten largest share positions make up 95.51% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-19-010838

Period
2019-09-30
Reported value
$162M
Holdings
17
Top 10 weight
95.51%
New
3
Sold out
3

Stakes and trades reported after 2019-09-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • OKUR ONKURE THERAPEUTICS INC: 13G 2,309,559 shares, 5.7% of the class, 13G filed 2026-11-20, 0001231919-26-001621Timeline
    Accepted , ingested
  • ENTX ENTERA BIO LTD: 13G 8,861,763 shares, 5.1% of the class, 13G filed 2026-10-30, 0001738048-26-000079Timeline
    Accepted , ingested
  • LYCA LYCIA THERAPEUTICS INC: 13G 6,850,237 shares, 11.9% of the class, 13G filed 2026-10-30, 0001738048-26-000077Timeline
    Accepted , ingested
  • FLSC FRAZIER LIFE SCIENCES ACQ-A: 13G 700,000 shares, 9% of the class, 13G filed 2026-10-27, 0001738048-26-000075Timeline
    Accepted , ingested
  • XFOR X4 PHARMACEUTICALS INC: 13G/A 7,644,072 shares, 7.6% of the class, 13G/A filed 2026-11-16, 0001738048-26-000100Timeline
    Accepted , ingested
  • VOR VOR BIOPHARMA INC: 13G/A 6,443,619 shares, 9.9% of the class, 13G/A filed 2026-11-16, 0001738048-26-000098Timeline
    Accepted , ingested
  • KRRO KORRO BIO INC: 13G/A 1,474,162 shares, 9.9% of the class, 13G/A filed 2026-11-16, 0001738048-26-000096Timeline
    Accepted , ingested
  • JBIO JADE BIOSCIENCES INC: 13G/A 3,858,984 shares, 5.9% of the class, 13G/A filed 2026-11-16, 0001738048-26-000094Timeline
    Accepted , ingested
  • HELP HELUS PHARMA INC: 13G/A 2,688,175 shares, 3.5% of the class, 13G/A filed 2026-11-16, 0001738048-26-000092Timeline
    Accepted , ingested
  • CBIO CRESCENT BIOPHARMA INC.: 13G/A 2,228,641 shares, 5.9% of the class, 13G/A filed 2026-11-16, 0001738048-26-000090Timeline
    Accepted , ingested
  • ACHV ACHIEVE LIFE SCIENCE INC: 13G/A 5,502,064 shares, 5.2% of the class, 13G/A filed 2026-11-16, 0001738048-26-000088Timeline
    Accepted , ingested

Largest buys vs the previous quarter

SecurityShares changeApprox. value
TXGnew+300,000$15.1M
MARINUS PHARMACEUTICALS INCadded+1,257,200$1.94M
RADIUS HEALTH INCnew+23,131$596K
PREVAIL THERAPEUTICS INCnew+4,408$54K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ORCHARD THERAPEUTICS PLCexited-676,252-$9.46M
TRICIDA INCreduced-209,398-$6.46M
KADMON HOLDINGS INCexited-422,141-$870K
GEMPHIRE THERAPEUTICS INCexited-798,066-$646K
KINIKSA PHARMACEUTICALS LTDreduced-35,183-$299K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2019

Share positions as resolved from 13F-HR 0000950123-19-010838, largest first. % of portfolio is the value over $161,989,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MISTMILESTONE PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: 2,066,529 shares; 2019Q3: 2,066,529 shares 2,066,529$38.5M23.79%0Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: 1,068,044 shares; 2019Q2: 1,611,329 shares; 2019Q3: 1,611,329 shares 1,611,329$32.6M20.13%0Timeline
RA PHARMACEUTICALS INCRA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: 594,713 shares; 2019Q1: 594,713 shares; 2019Q2: 670,350 shares; 2019Q3: 670,350 shares 670,350$15.9M9.79%0
TXG10X GENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: 300,000 shares 300,000$15.1M9.33%newTimeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: 423,176 shares; 2019Q1: 809,323 shares; 2019Q2: 1,072,348 shares; 2019Q3: 1,072,348 shares 1,072,348$12.9M7.95%0Timeline
LA JOLLA PHARMACEUTICAL COLA JOLLA PHARMACEUTICAL COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: 1,003,600 shares; 2019Q2: 1,251,898 shares; 2019Q3: 1,251,898 shares 1,251,898$11M6.8%0
ObsEva SAObsEva SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 1,159,789 shares; 2018Q4: 1,159,789 shares; 2019Q1: 1,159,789 shares; 2019Q2: 1,159,789 shares; 2019Q3: 1,159,789 shares 1,159,789$9.66M5.96%0
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 3,061,091 shares; 2018Q4: 3,061,091 shares; 2019Q1: 3,061,091 shares; 2019Q2: 2,708,207 shares; 2019Q3: 2,708,207 shares 2,708,207$7.76M4.79%0Timeline
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 1,284,931 shares; 2018Q4: 1,284,931 shares; 2019Q1: 970,630 shares; 2019Q2: 637,884 shares; 2019Q3: 637,884 shares 637,884$7.4M4.57%0Timeline
MARINUS PHARMACEUTICALS INCMARINUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 672,271 shares; 2018Q4: 1,258,964 shares; 2019Q1: 1,258,964 shares; 2019Q2: 1,258,964 shares; 2019Q3: 2,516,164 shares 2,516,164$3.88M2.39%+1,257,200
TRICIDA INCTRICIDA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 650,585 shares; 2018Q4: 650,585 shares; 2019Q1: 650,585 shares; 2019Q2: 289,746 shares; 2019Q3: 80,348 shares 80,348$2.48M1.53%-209,398
KINIKSA PHARMACEUTICALS LTDKINIKSA PHARMACEUTICALS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 327,777 shares; 2018Q4: 327,777 shares; 2019Q1: 327,777 shares; 2019Q2: 312,320 shares; 2019Q3: 277,137 shares 277,137$2.36M1.46%-35,183
BELLEROPHON THERAPEUTICS INCBELLEROPHON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 2,274,370 shares; 2018Q4: 2,274,370 shares; 2019Q1: 2,417,227 shares; 2019Q2: 2,417,227 shares; 2019Q3: 2,417,227 shares 2,417,227$1.17M0.72%0
RADIUS HEALTH INCRADIUS HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: 23,131 shares 23,131$596K0.37%new
CONSTELLATION PHARMACEUTICALCONSTELLATION PHARMACEUTICALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: 66,667 shares; 2018Q4: 66,667 shares; 2019Q1: 66,667 shares; 2019Q2: 66,667 shares; 2019Q3: 66,667 shares 66,667$431K0.27%0
YUMANITY THERAPEUTICS INCYUMANITY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: 848,610 shares; 2019Q1: 722,890 shares; 2019Q2: 221,267 shares; 2019Q3: 221,267 shares 221,267$187K0.12%0
PREVAIL THERAPEUTICS INCPREVAIL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2017Q4: restricted; 2018Q1: not loaded; 2018Q2: not loaded; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: 4,408 shares 4,408$54K0.03%new

Sold out in Q3 2019

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ORCHARD THERAPEUTICS PLCORCHARD THERAPEUTICS PLC676,252$9.46Mshares
KADMON HOLDINGS INCKADMON HOLDINGS INC422,141$870Kshares
GEMPHIRE THERAPEUTICS INCGEMPHIRE THERAPEUTICS INC798,066$646Kshares

How Q3 2019 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-19-010838 base2019-11-13acceptance time not in the bulk data set